TokenPost·
Jaguar Health Targets Mid-2027 MVID Filing After More Than $10 Million in Debt Reduction

Participants in the pivotal pediatric MVID trial have entered extension dosing. Jaguar also plans to seek breakthrough therapy designation in 2027.
Every crypto headline. One feed. Updated every minute.

Participants in the pivotal pediatric MVID trial have entered extension dosing. Jaguar also plans to seek breakthrough therapy designation in 2027.